Published in Nephron on January 01, 1991
Peritoneal changes in patients on long-term peritoneal dialysis. Nat Rev Nephrol (2013) 1.20
Treatment of severe ultrafiltration failure with nonglucose dialysis solutions in patients with and without peritoneal sclerosis. NDT Plus (2008) 0.78
Effect of the peritoneal dialysis prescription on pentosidine in children. Pediatr Nephrol (2003) 0.76
The breakdown of preformed peritoneal advanced glycation end products by intraperitoneal alagebrium. J Korean Med Sci (2009) 0.75
Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol (1994) 3.22
Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol (2000) 3.03
Creatinine clearance during cimetidine administration for measurement of glomerular filtration rate. Lancet (1992) 3.02
Association of serum fetuin-A levels with mortality in dialysis patients. Kidney Int (2007) 2.42
Quality of life in patients on chronic dialysis: self-assessment 3 months after the start of treatment. The Necosad Study Group. Am J Kidney Dis (1997) 2.37
Physical symptoms and quality of life in patients on chronic dialysis: results of The Netherlands Cooperative Study on Adequacy of Dialysis (NECOSAD) Nephrol Dial Transplant (1999) 2.04
Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual Life Res (2002) 1.79
Growth factors VEGF and TGF-beta1 in peritoneal dialysis. J Lab Clin Med (1999) 1.71
Glucose, insulin and potassium applied as perioperative hyperinsulinaemic normoglycaemic clamp: effects on inflammatory response during coronary artery surgery. Br J Anaesth (2005) 1.62
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med (1993) 1.55
Circadian rhythm of glomerular filtration rate in normal individuals. Clin Sci (Lond) (1989) 1.53
A rise in plasma creatinine that is not a sign of renal failure: which drugs can be responsible? J Intern Med (1999) 1.52
Perioperative hyperinsulinaemic normoglycaemic clamp causes hypolipidaemia after coronary artery surgery. Br J Anaesth (2008) 1.49
The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int (1994) 1.48
When to initiate dialysis: effect of proposed US guidelines on survival. Lancet (2001) 1.47
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Vascular and interstitial changes in the peritoneum of CAPD patients with peritoneal sclerosis. Perit Dial Int (2000) 1.44
The effect of indomethacin on kidney function and plasma renin activity in man. Nephron (1976) 1.42
Effect of electric charge on the transperitoneal transport of plasma proteins during CAPD. Nephrol Dial Transplant (1996) 1.41
Indirect measurement of lymphatic absorption with inulin in continuous ambulatory peritoneal dialysis (CAPD) patients. Perit Dial Int (1990) 1.40
Predialytic period and baseline peritoneal membrane status: any connection? Perit Dial Int (2010) 1.39
Icodextrin with nitroprusside increases ultrafiltration and peritoneal transport during long CAPD dwells. Kidney Int (1998) 1.38
Peritoneal sclerosis in chronic peritoneal dialysis patients: analysis of clinical presentation, risk factors, and peritoneal transport kinetics. Perit Dial Int (1997) 1.37
Intraperitoneal administration of recombinant human erythropoietin. Perit Dial Int (1992) 1.34
Cancer antigen 125: a bulk marker for the mesothelial mass in stable peritoneal dialysis patients. Nephrol Dial Transplant (1995) 1.32
Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment. Neth J Med (2011) 1.28
Measurement of residual renal function in patients treated with continuous ambulatory peritoneal dialysis. J Am Soc Nephrol (1996) 1.25
Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol (1997) 1.25
Acute interstitial nephritis: a clinical and morphological study in 27 patients. Nephrol Dial Transplant (1990) 1.23
Lower numbers of erythrocytes and lower levels of hemoglobin in periodontitis patients compared to control subjects. J Clin Periodontol (2001) 1.23
Cardiac and hemodynamic effects of hemodialysis and ultrafiltration. Am J Kidney Dis (2000) 1.22
Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int (1999) 1.20
Experimental chronic serum sickness in rats. A model of immune complex glomerulonephritis and systemic immune complex deposition. Int Arch Allergy Appl Immunol (1979) 1.16
IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans. J Immunol (2001) 1.14
Interleukin-6 mediates host defense responses induced by abdominal surgery. Surgery (1993) 1.13
Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. The NECOSAD Study Group. Am J Kidney Dis (2000) 1.13
Relationship between elevated creatine phosphokinase and the clinical spectrum of rhabdomyolysis. Nephrol Dial Transplant (1994) 1.13
The clinical course of IgA nephropathy in adults. Clin Nephrol (1977) 1.12
Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial (1999) 1.12
A circadian rhythm of proteinuria in patients with a nephrotic syndrome. Clin Sci (Lond) (1985) 1.11
Analysis of ultrafiltration failure in peritoneal dialysis patients by means of standard peritoneal permeability analysis. Perit Dial Int (1997) 1.09
Tumour lysis syndrome and acute renal failure in Burkitt's lymphoma. Description of 2 cases and a review of the literature on prevention and management. Neth J Med (1994) 1.08
Bicarbonate/lactate-based peritoneal dialysis solution increases cancer antigen 125 and decreases hyaluronic acid levels. Kidney Int (2001) 1.07
Phase I and pharmacologic study of the novel indoloquinone bioreductive alkylating cytotoxic drug E09. J Natl Cancer Inst (1994) 1.07
Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int (1994) 1.06
Peritoneal transport characteristics with glucose polymer based dialysate. Kidney Int (1996) 1.04
Intestinal permeability, circulating endotoxin, and postoperative systemic responses in cardiac surgery patients. J Cardiothorac Vasc Anesth (1996) 1.03
Chemokines produced by mesothelial cells: huGRO-alpha, IP-10, MCP-1 and RANTES. Clin Exp Immunol (1998) 1.03
Changes in employment status in end-stage renal disease patients during their first year of dialysis. Perit Dial Int (2002) 1.03
The standard peritoneal permeability analysis: a tool for the assessment of peritoneal permeability characteristics in CAPD patients. Kidney Int (1995) 1.03
Quality of life over time in dialysis: the Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group. Kidney Int (1999) 1.03
Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis (1993) 1.02
Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int (2006) 1.02
The phospholipid composition and cholesterol content of platelet-derived microparticles: a comparison with platelet membrane fractions. J Thromb Haemost (2005) 1.02
Longitudinal follow-up of CA125 in peritoneal effluent. Kidney Int (1997) 1.00
Glomerular filtration rate measurements by 125I-iothalamate should be corrected for inaccurate urine collections with 131I-hippuran. Clin Nephrol (2009) 0.98
Characterization of the content of occluded biliary endoprostheses. Endoscopy (1987) 0.98
Treatment of the nephrotic syndrome with indomethacin. Nephron (1978) 0.97
Dialysate markers of peritoneal tissue during peritonitis and in stable CAPD. Perit Dial Int (1995) 0.97
Vascular endothelial growth factor in peritoneal dialysis: a longitudinal follow-up. J Lab Clin Med (2001) 0.96
Cancer antigen 125 is locally produced in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Perit Dial Int (1994) 0.96
The mesothelial cells in CAPD effluent and their relation to peritonitis incidence. Perit Dial Int (1991) 0.96
Plasma antibody levels in periodontitis patients and controls. J Clin Periodontol (2004) 0.96
Wegener's granulomatosis. A clinicopathological study in twelve patients. Neth J Med (1978) 0.94
A prospective study of peritoneal transport in CAPD patients. Kidney Int (1994) 0.94